[Progresses in diagnosis and treatment of intrauterine infection with cytomegalovirus and human parvovirus B19].
Wu
Wan-fang
WF
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000187:drug effects; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000635:transmission; D016731:Erythema Infectiosum / Q000175:diagnosis* / Q000188:drug therapy / Q000635:transmission; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis* / Q000188:drug therapy; D015774:Ganciclovir / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D010322:Parvoviridae Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000635:transmission; D016732:Parvovirus B19, Human / Q000187:drug effects; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000821:virology; D011296:Prenatal Diagnosis / Q000379:methods; D014599:Uterus
D000998:Antiviral Agents; D015774:Ganciclovir